Royal Bank Of Canada Pa Vmed Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.22 - $0.5 $26 - $61	-122 Reduced 14.32%	730 $0
Q2 2023 Aug 14, 2023	BUY	$0.35 - $0.56 $164 - $263	470 Added 123.04%	852 $0
Q1 2023 May 15, 2023	BUY	$0.36 - $0.63 $137 - $240	382 New	382 $0
Q3 2022 Nov 14, 2022	BUY	$0.57 - $34.65 $293 - $17,844	515 New	515 $0
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $3,795 - $6,295	-4,465 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.16 - $2.5 $52,597 - $113,357	-45,343 Reduced 91.04%	4,465 $6,000
Q4 2021 Feb 14, 2022	BUY	$2.46 - $8.74 $93,120 - $330,843	37,854 Added 316.66%	49,808 $123,000
Q3 2021 Nov 15, 2021	BUY	$5.1 - $9.39 $35,786 - $65,889	7,017 Added 142.13%	11,954 $102,000
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $19,501 - $33,966	4,937 New	4,937 $32,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $106M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.